Differences between MS patient characteristics in clinical trials and real populations

Stephen Krieger, physician: We are here at the ECTRIMS conference [European Committee for Treatment and Research in Multiple Sclerosis] in Amsterdam, the Netherlands, in the fall of 2022. It’s nice to be at a personal event. A lot of new work is presented here. A piece of work from Dr Ruth Dobson and colleagues on … Read more

International committee proposes framework for MS disease progression driven by pathophysiological mechanisms, not clinical phenotype

For many years, multiple sclerosis (MS) has been defined by 3 clinical courses: relapsing-remitting, primary progressive, and secondary progressive. Now, however, a newly published paper from the International Advisory Committee on Clinical Trials in Multiple Sclerosis suggests that patients with MS have qualitatively similar pathological features, independent of clinical course, and that disability progression is … Read more

Radiologic Techs Share Inside View of Critical Role in Healthcare

TOPEKA, Kan. (WIBW) – They are not doctors or nurses, but the work of radiology technicians involves every aspect of medicine. This is Radiologic Technology Week, set aside to recognize the health professionals who capture the images doctors and specialists use to diagnose and treat patients. At Stormont Vail, Mike Liberato and Hayley McGivern are … Read more

Unique compound of CNM-Au8 to treat MS and ALS: Michael Hotchkin

WATCH TIME: 2 minutes “It’s fascinating how many different neurodegenerative diseases share a commonality of energetic dysfunction. We have preclinical models that suggest efficacy for a variety of different neurodegenerative diseases: MS, ALS, Alzheimer’s disease and multiple other models.” CNM-Au8, an investigational agent consisting of a gold nanocrystal suspension developed by Clene Nanomedicine, represents a … Read more